BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Current Mechanistic Approaches to the Chemoprevention of Cancer

  • Steele, Vernon E. (Chemoprevention Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health)
  • Published : 2003.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

The prevention of cancer is one of the most important public health and medical practices of the $21^{st}$ century. We have made much progress in this new emerging field, but so much remains to be accomplished before widespread use and practice become common place. Cancer chemoprevention encompasses the concepts of inhibition, reversal, and retardation of the cancer process. This process, called carcinogenesis, requires 20-40 years to reach the endpoint called invasive cancer. It typically follows multiple, diverse and complex pathways in a stochastic process of clonal evolution. These pathways appear amenable to inhibition, reversal or retardation at various points. We must therefore identify key pathways in the evolution of the cancer cell that can be exploited to prevent this carcinogenesis process. Basic research is identifying many genetic lesions and epigenetic processes associated with the progression of precancer to invasive disease. Many of these early precancerous lesions favor cell division over quiescence and protect cells against apoptosis when signals are present. Many oncogenes are active during early development and are reactivated in adulthood by aberrant gene promoting errors. Normal regulatory genes are mutated, making them insensitive to normal regulatory signals. Tumor suppressor genes are deleted or mutated rendering them inactive. Thus there is a wide range of defects in cellular machinery which can lead to evolution of the cancer phenotype. Mistakes may not have to appear in a certain order for cells to progress along the cancer pathway. To conquer this diverse disease, we must attack multiple key pathways at once for a predetermined period of time. Thus, agent combination prevention strategies are essential to decrease cancer morbidity. Furthermore, each cancer type may require custom combination of prevention strategies to be successful.

Keywords

References

  1. Altucci, L. and Gronemeyer, H. (2001) The promise of retinoids to fIght against cancer. Nat. Rev. Cancer 1, 181-193. https://doi.org/10.1038/35106036
  2. Boone, C. W., Kelloff, G. J. and Steele, V. E. (1992) The natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res. 52, 1651- 1659.
  3. Chen, G., Wilson, R., McKillop, J. H. and Walker, J. J. (1994) The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells. Immunol. Invest. 23, 269-279. https://doi.org/10.3109/08820139409066823
  4. Cho, K. H., Pezzuto, J. M., Bolton, J. L., Steele, V. E., Kelloff, G. J., Lee, S. K. and Constantinou, A. (2000) Selection of Cancer chemopreventive agents based in inhibition of topoisomerase II activity. Eur. J. Cancer 36, 2146-2156. https://doi.org/10.1016/S0959-8049(00)00300-2
  5. Cohen, L. A., Pittman, B., Wang, C. X., Aliaga, C. and Moyer, J. D. (2001) LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N- methylurea-induced rat mammary tumor model. Cancer Res. 61, 8683-8686.
  6. Dardes, R. C., O'Regan, R. M., Gajdos, C., Robinson, S. P., Bentrem, D., De Los Reyes, A. and Jordan, V. C. (2002) Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Clin. Cancer Res. 8, 1995-2001.
  7. Dobbs, S. P., Hewett, P. W., Johnson, I. R., Carmichael, J. and Murray, J. C. (1997) Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br. J. Cancer 76, 1410-1415. https://doi.org/10.1038/bjc.1997.571
  8. DuBois, R. N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K. and Lanahan, A. (1994) Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol. 266, 822-827.
  9. Egner, P. A., Wang, J. B., Zhu, Y. R., Zhang, B. C., Wu, Y., Zhang, Q. N., Qian, G. S., Kuang, S. Y., Gange, S. J., Jacobson, L. P., Helzlsouer, K. J., Bailey, G. S., Groopman, J. D. and Kensler, T. W. (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA 98, 14601-14606. https://doi.org/10.1073/pnas.251536898
  10. Garcia, S. B., Novelli, M. and Wright, N. A. (2000) The clonal origin and clonal evolution of epithelial tumours. Int. J. Exp. Pathol. 81, 89-116. https://doi.org/10.1046/j.1365-2613.2000.00142.x
  11. Hecht, S. S. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3, 461-469. https://doi.org/10.1016/S1470-2045(02)00815-X
  12. Hempel, S. L., Monick, M. M. and Hunninghake, G. W. (1994) Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest. 93, 391-396. https://doi.org/10.1172/JCI116971
  13. Kelloff, G. J., Lubet, R. A., Lieberman, R., Eisenhauer, K., Steele, Y. E., Crowell, J. A., Hawk, E., T., Boone, C. W. and Sigman, C. C. (1998) Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers & Prev 7, 65-78.
  14. Newmark, H. L., Wargovich, M. J. and Bruce, W. R. (1984) Colon cancer and dietary fat calcium and phosphate: a hypothesis. J. Natl. Cancer Inst. 72, 1323-1325.
  15. Prescott, S. M. and White, R. L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87, 783-786. https://doi.org/10.1016/S0092-8674(00)81983-2
  16. Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T. and Hla, T. (1994) Induction of cyclooxygenase-2 by interleukin-1. Evidence for post-transcriptional regulation. J. BioI. Chem. 269, 11769-11775.
  17. Robertson, J. F. (2001) Faslodex (ICI 182,780), a novel estrogen receptor down regulator-future possibilities in breast cancer. J. Steroid Biochem. Mol. BioI. 79, 209-212. https://doi.org/10.1016/S0960-0760(01)00138-8
  18. Scharovsky, O. G., Rozados, Y. R., Gervasoni, S.l. and Matar, P. (2000) Inhibition of ras oncogene: a novel approach to antineoplastic therapy. J. Biomed. Sci. 7, 292-298.
  19. Sharma, S., Ghoddoussi, M., Gao, P,. Kelloff, G. J., Steele, V. E. and Kopelovich, L. (2001) A quantitative angiogenesis model for efficacy testing of chemopreventive agents. Anticancer Res. 21, 3829-3838.
  20. Smith, W. L., Garavito, R. M. and DeWitt, D. L. (1996) Prostaglandin endoperoxide H synthase (cyclooxygenases )-1 and -2. J. Biol. Chem. 271, 33157-33160. https://doi.org/10.1074/jbc.271.52.33157
  21. Steele, V. E., Kelloff, G. J., Balentine, D., Boone, C. W., Mehta, R., Bagheri, D., Sigman, C. C., Zhu, S. and Sharma, S. (2000) Comparative chemopreventive mechanisms of green tea, black tea, and selected polphenol extracts measured by in vitro bioassays. Carcinogenesis 21, 63-67. https://doi.org/10.1093/carcin/21.1.63
  22. Sun, S. Y. and Lotan, R. (2002) Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 41, 41-55. https://doi.org/10.1016/S1040-8428(01)00144-5
  23. Tao, L., Li, Y., Wang, W., Kramer, P. M., Gunning, W. T., Lubet, R. A., Steele, V. E. and Pereira, M. A. (2002) Effect of budesonide on the methylation of mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors. Mol. Carcinog. 35, 93-102. https://doi.org/10.1002/mc.10078
  24. Voest, E. E. (1996) Inhibitors of angiogenesis in a clinical perspective. Anticancer Drugs 7, 723-727. https://doi.org/10.1097/00001813-199609000-00001
  25. Wargovich, M. J., Eng, V. W. S., Newmark, H. L. and Bruce, W. R. (1983) Calcium ameliorates the toxic effects of deoxycholic acid on colonic epithelium. Carcinogenesis 4, 1205-1207. https://doi.org/10.1093/carcin/4.9.1205
  26. Williams, C. S. and DuBois, R. N. (1996) Prostaglandin endoperoxide synthase: Why two isoforms? Am. J. Physiol. 270, 393-400.
  27. Wolf, C. R., Mahmood, A., Henderson, C. J., McLeod, R., Manson, M. M., Neal, G. E. and Hayes, J. D. (1996) Modulation of the cytochrome P450 system as a mechanism of chemoprotection. IARC Sci. Publ. 139, 165-173.

Cited by

  1. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization vol.46, pp.2, 2007, https://doi.org/10.1016/j.vph.2006.06.015
  2. High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones vol.1076, pp.1-2, 2005, https://doi.org/10.1016/j.chroma.2005.04.024
  3. Germinated Brown Rice and Its Role in Human Health vol.53, pp.5, 2013, https://doi.org/10.1080/10408398.2010.542259
  4. Plant foods for human health: research challenges vol.65, pp.02, 2006, https://doi.org/10.1079/PNS2006492
  5. Bio-protective effects of glucosinolates – A review vol.42, pp.10, 2009, https://doi.org/10.1016/j.lwt.2009.05.023
  6. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis vol.19, pp.2, 2010, https://doi.org/10.1097/CEJ.0b013e3283362a3e
  7. Anticancer Drugs from Marine Flora: An Overview vol.2010, 2010, https://doi.org/10.1155/2010/214186
  8. Garlic: Nature's Protection Against Physiological Threats vol.49, pp.6, 2009, https://doi.org/10.1080/10408390802145344
  9. Combinatorial chemopreventive effect of butyric acid, nicotinamide and calcium glucarate against the 7,12-dimethylbenz(a)anthracene induced mouse skin tumorigenesis attained by enhancing the induction of intrinsic apoptotic events vol.226, 2015, https://doi.org/10.1016/j.cbi.2014.11.018
  10. Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis vol.14, pp.4, 2005, https://doi.org/10.1097/00008469-200508000-00012
  11. Epstein-Barr Virus-infected Akata Cells Are Sensitive to Histone Deacetylase Inhibitor TSA-provoked Apoptosis vol.38, pp.6, 2005, https://doi.org/10.5483/BMBRep.2005.38.6.755
  12. Nigella sativa: Reduces the Risk of Various Maladies vol.50, pp.7, 2010, https://doi.org/10.1080/10408390902768797
  13. Vitamin E succinate inhibits NF-κB and prevents the development of a metastatic phenotype in prostate cancer cells: Implications for chemoprevention vol.67, pp.6, 2007, https://doi.org/10.1002/pros.20468
  14. Effects of Germinated Brown Rice Extracts with Enhanced Levels of GABA on Cancer Cell Proliferation and Apoptosis vol.7, pp.1, 2004, https://doi.org/10.1089/109662004322984653